Rohlin M
Department of Oral Radiology, Lund University, Malmö, Sweden.
Oral Surg Oral Med Oral Pathol. 1993 May;75(5):650-7. doi: 10.1016/0030-4220(93)90242-v.
Thirty-five patients each with a tentative diagnosis of osteomyelitis of the mandible were examined with 99Tcm-labeled phosphorus compounds. The scintigraphic findings were compared with the radiographic features and related to disease stages to evaluate the diagnostic potential of bone scintigraphy in different disease stages. The scintigraphy was valuable to exclude bone tissue involvement in some patients with clinical signs and symptoms similar to those of osteomyelitis and with equivocal radiographic findings. In 13 patients with chronic osteomyelitis, scintigraphy revealed a larger extent of the lesion than the radiography. In lesions with permeated bone destructions with penetration of the cortex, the uptake of 99Tcm was higher than in lesions with a motheaten or sclerotic appearance. This study supports the view that 99Tcm-bone scintigraphy is a useful tool at various stages of osteomyelitis, that is, in its early detection, in the treatment or biopsy planning, and in the evaluation of the efficacy of treatment.
对35例初步诊断为下颌骨骨髓炎的患者进行了99锝标记的磷化合物检查。将骨闪烁显像结果与放射学特征进行比较，并与疾病阶段相关联，以评估骨闪烁显像在不同疾病阶段的诊断潜力。对于一些有类似于骨髓炎的临床体征和症状且放射学表现不明确的患者，骨闪烁显像对于排除骨组织受累很有价值。在13例慢性骨髓炎患者中，骨闪烁显像显示的病变范围比X线片更大。在伴有皮质穿透的弥漫性骨质破坏的病变中，99锝的摄取高于呈虫蚀状或硬化外观的病变。本研究支持以下观点，即99锝骨闪烁显像在骨髓炎的各个阶段都是一种有用的工具，即在早期检测、治疗或活检计划以及治疗效果评估中。
